160 related articles for article (PubMed ID: 12360467)
1. Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.
Kim GE; Bae HI; Park HU; Kuan SF; Crawley SC; Ho JJ; Kim YS
Gastroenterology; 2002 Oct; 123(4):1052-60. PubMed ID: 12360467
[TBL] [Abstract][Full Text] [Related]
2. Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach.
Shiratsu K; Higuchi K; Nakayama J
Cancer Sci; 2014 Jan; 105(1):126-33. PubMed ID: 24138592
[TBL] [Abstract][Full Text] [Related]
3. Mucin gene expression in the ileoanal reservoir is altered and may be relevant to the risk of inflammation and dysplasia.
Sylvester PA; Walsh M; Myerscough N; Warren BF; Corfield AP; Thomas MG; Durdey P
Gut; 2002 Sep; 51(3):386-91. PubMed ID: 12171961
[TBL] [Abstract][Full Text] [Related]
4. Sequence-Specific Mucins for Glycocalyx Engineering.
Pan H; Colville MJ; Supekar NT; Azadi P; Paszek MJ
ACS Synth Biol; 2019 Oct; 8(10):2315-2326. PubMed ID: 31500407
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer.
Pothuraju R; Krishn SR; Gautam SK; Pai P; Ganguly K; Chaudhary S; Rachagani S; Kaur S; Batra SK
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32168759
[TBL] [Abstract][Full Text] [Related]
6. Impaired Glycosylation of Gastric Mucins Drives Gastric Tumorigenesis and Serves as a Novel Therapeutic Target.
Arai J; Hayakawa Y; Tateno H; Murakami K; Hayashi T; Hata M; Matsushita Y; Kinoshita H; Abe S; Kurokawa K; Oya Y; Tsuboi M; Ihara S; Niikura R; Suzuki N; Iwata Y; Shiokawa T; Shiomi C; Uekura C; Yamamoto K; Fujiwara H; Kawamura S; Nakagawa H; Mizuno S; Kudo T; Takahashi S; Ushiku T; Hirata Y; Fujii C; Nakayama J; Shibata S; Woods S; Worthley DL; Hatakeyama M; Wang TC; Fujishiro M
Gastroenterology; 2024 Apr; ():. PubMed ID: 38583723
[TBL] [Abstract][Full Text] [Related]
7. A gastric invasive tubular adenocarcinomatous lesion arising from foveolar-type neoplasia: molecular histogenesis.
Sugai T; Uesugi N; Hamada K; Nagahashi T; Horikawa Y; Suzuki M; Sugimoto R; Yanagawa N
Clin J Gastroenterol; 2024 Apr; ():. PubMed ID: 38662253
[TBL] [Abstract][Full Text] [Related]
8. Mucin expression profile in pancreatic cancer and the precursor lesions.
Nagata K; Horinouchi M; Saitou M; Higashi M; Nomoto M; Goto M; Yonezawa S
J Hepatobiliary Pancreat Surg; 2007; 14(3):243-54. PubMed ID: 17520199
[TBL] [Abstract][Full Text] [Related]
9. Subtyping of intraductal papillary mucinous neoplasms - pitfalls of MUC1 immunohistochemistry.
Klausen P; Kovacevic B; Toxvaerd A; Kalaitzakis E; Karstensen JG; Rift CV; Hansen CP; Storkholm J; Vilmann P; Hasselby JP
APMIS; 2019 Jan; 127(1):27-32. PubMed ID: 30549137
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic KRAS, Mucin 4, and Activin A-Mediated Fibroblast Activation Cooperate for PanIN Initiation.
Hu CM; Huang CC; Hsu MF; Chien HJ; Wu PJ; Chen YI; Jeng YM; Tang SC; Chung MH; Shen CN; Chang MC; Chang YT; Tien YW; Lee WH
Adv Sci (Weinh); 2023 Dec; 10(36):e2301240. PubMed ID: 37964407
[TBL] [Abstract][Full Text] [Related]
11. Differential Expression and Diagnostic Value of MUC5AC Glycoforms in Pancreatic Ductal Adenocarcinoma.
Manne A; Yu L; Hart PA; Tsung A; Esnakula A
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835525
[TBL] [Abstract][Full Text] [Related]
12. Chromatin accessibility uncovers KRAS-driven FOSL2 promoting pancreatic ductal adenocarcinoma progression through up-regulation of CCL28.
Zhang S; Li P; Li J; Gao J; Qi Q; Dong G; Liu X; Jiao Q; Wang Y; Du L; Zhan H; Xu S; Wang C
Br J Cancer; 2023 Aug; 129(3):426-443. PubMed ID: 37380804
[TBL] [Abstract][Full Text] [Related]
13. Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Model: A Proof-of-Concept Study.
Turner MA; Cox KE; Neel N; Amirfakhri S; Nishino H; Clary BM; Hosseini M; Natarajan G; Mallya K; Mohs AM; Hoffman RM; Batra SK; Bouvet M
J Pers Med; 2023 May; 13(5):. PubMed ID: 37241027
[TBL] [Abstract][Full Text] [Related]
14. Predictive Value of MUC5AC Signature in Pancreatic Ductal Adenocarcinoma: A Hypothesis Based on Preclinical Evidence.
Manne A; Kasi A; Esnakula AK; Paluri RK
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175794
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Donor Pancreata Defines the Transcriptomic Signature and Microenvironment of Early Neoplastic Lesions.
Carpenter ES; Elhossiny AM; Kadiyala P; Li J; McGue J; Griffith BD; Zhang Y; Edwards J; Nelson S; Lima F; Donahue KL; Du W; Bischoff AC; Alomari D; Watkoske HR; Mattea M; The S; Espinoza CE; Barrett M; Sonnenday CJ; Olden N; Chen CT; Peterson N; Gunchick V; Sahai V; Rao A; Bednar F; Shi J; Frankel TL; Pasca di Magliano M
Cancer Discov; 2023 Jun; 13(6):1324-1345. PubMed ID: 37021392
[TBL] [Abstract][Full Text] [Related]
16. Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer.
Muilenburg KM; Isder CC; Radhakrishnan P; Batra SK; Ly QP; Carlson MA; Bouvet M; Hollingsworth MA; Mohs AM
Cancer Lett; 2023 May; 561():216150. PubMed ID: 36997106
[TBL] [Abstract][Full Text] [Related]
17. Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early pre-neoplastic pancreatic lesions.
Carpenter ES; Elhossiny AM; Kadiyala P; Li J; McGue J; Griffith B; Zhang Y; Edwards J; Nelson S; Lima F; Donahue KL; Du W; Bischoff AC; Alomari D; Watkoske H; Mattea M; The S; Espinoza C; Barrett M; Sonnenday CJ; Olden N; Peterson N; Gunchick V; Sahai V; Rao A; Bednar F; Shi J; Frankel TL; Di Magliano MP
bioRxiv; 2023 Jan; ():. PubMed ID: 36712058
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Clinical Significance of MUC5AC in Biliary Tract Cancers.
Benson KK; Sheel A; Rahman S; Esnakula A; Manne A
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672382
[TBL] [Abstract][Full Text] [Related]
19. Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201.
Tsang KY; Fantini M; Zaki A; Mavroukakis SA; Morelli MP; Annunziata CM; Arlen PM
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291783
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-mediated transcriptional regulation of human
An SY; Kim KS; Cho JH; Kim HD; Kim CH; Lee YC
Front Mol Biosci; 2022; 9():985648. PubMed ID: 36172045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
